Comparing Clomiphen Citrate Plus HMG with Clomiphen Citrate Plus RFSH in IUI Cycles in Couples with Unexplained or Male Factor Infertility: A Prospective Randomized Study

Overview

Journal Iran J Reprod Med

Specialty Reproductive Medicine

Date 2014 Mar 19

PMID 24639752

Citations 3

Authors

Azam Azargoon

Marjan Bahrami

Jafar Alavy Toussy

Affiliations

Soon will be listed here.

Abstract

Background: Different protocols are used for controlled ovarian hyper stimulation (COH), but the optimal method has not yet been determined.

Objective: The aim of this study was to compare the outcome of controlled ovarian stimulation (COS) using clomiphen citrate (CC) plus HMG versus CC plus rFSH in intra uterine insemination cycles (IUI).

Materials And Methods: 144 women with unexplained or male factor infertility undergoing IUI cycles were randomized (72 patients in CC plus rFSH group and 72 patients in CC plus HMG group) and included in this single blind study from October 2006 to June 2010. The primary outcomes were clinical and ongoing pregnancy rates. The number of dominant follicles, mean of follicular size, endometrial thickness on the day of HCG administration, total dose of gonadotropins and duration of stimulation with gonadotropins were secondary outcomes.

Results: Clinical and ongoing pregnancy rates were not significantly different in the two groups .There was a significant higher multiple pregnancy rate in CC plus rFSH group (33.3%) versus CC plus HMG group (12.5%; p<0.005). There were no statistically significant differences in the secondary outcomes between the two groups.

Conclusion: According to our results it seems that CC plus HMG is a more suitable and cost-effective regimen than CC plus rFSH in IUI cycles in patients with unexplained or male factor infertility.

Citing Articles

Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.

Cantineau A, Rutten A, Cohlen B Cochrane Database Syst Rev. 2021; 11:CD005356.

PMID: 34739136 PMC: 8570324. DOI: 10.1002/14651858.CD005356.pub3.

Doctors' Preferences for Controlled Ovarian Stimulation Protocols in Intrauterine Insemination.

Zeng M, Wen Y, Jiang M, Xing W, Tao X, Cai L Mater Sociomed. 2015; 27(4):248-50.

PMID: 26543416 PMC: 4610623. DOI: 10.5455/msm.2015.27.248-250.

Effect of vaginal misoprostol on pregnancy rate after intrauterine insemination: a randomized controlled trial.

Zahiri Sorouri Z, Asgharnia M, Gholampoor A Iran J Reprod Med. 2015; 13(1):9-14.

PMID: 25653670 PMC: 4306979.

References

Mahani I, Afnan M . The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle. J Pak Med Assoc. 2004; 54(10):503-5. View

Platteau P, Nyboe Andersen A, Balen A, Devroey P, Sorensen P, Helmgaard L . Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod. 2006; 21(7):1798-804. DOI: 10.1093/humrep/del085. View

Guzick D, Carson S, Coutifaris C, Overstreet J, Factor-Litvak P, Steinkampf M . Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med. 1999; 340(3):177-83. DOI: 10.1056/NEJM199901213400302. View

. Multiple gestation pregnancy. The ESHRE Capri Workshop Group. Hum Reprod. 2000; 15(8):1856-64. View

Zeyneloglu H, Arici A, Olive D, Duleba A . Comparison of intrauterine insemination with timed intercourse in superovulated cycles with gonadotropins: a meta-analysis. Fertil Steril. 1998; 69(3):486-91. DOI: 10.1016/s0015-0282(97)00552-9. View

Zayed F, Lenton E, Cooke I . Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility. Hum Reprod. 1998; 12(11):2408-13. DOI: 10.1093/humrep/12.11.2408. View

Sagnella F, Moro F, Lanzone A, Tropea A, Martinez D, Capalbo A . A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. Fertil Steril. 2010; 95(2):689-94. DOI: 10.1016/j.fertnstert.2010.08.044. View

OLeary A, Griffiths A, Evans J, Pugh N . Perifollicular blood flow and pregnancy in superovulated intrauterine insemination (IUI) cycles: an observational comparison of recombinant follicle-stimulating hormone (FSH) and urinary gonadotropins. Fertil Steril. 2009; 92(4):1366-1368. DOI: 10.1016/j.fertnstert.2009.02.046. View

Gerli S, Casini M, Unfer V, Costabile L, Bini V, Di Renzo G . Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness. Fertil Steril. 2004; 82(3):573-8. DOI: 10.1016/j.fertnstert.2004.04.026. View

10.

Stone B, Vargyas J, Ringler G, Stein A, Marrs R . Determinants of the outcome of intrauterine insemination: analysis of outcomes of 9963 consecutive cycles. Am J Obstet Gynecol. 1999; 180(6 Pt 1):1522-34. DOI: 10.1016/s0002-9378(99)70048-7. View

11.

Cohlen B, Te Velde E, van Kooij R, Looman C, Habbema J . Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod. 1998; 13(6):1553-8. DOI: 10.1093/humrep/13.6.1553. View

12.

Demirol A, Gurgan T . Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study. Hum Reprod. 2006; 22(1):97-100. DOI: 10.1093/humrep/del335. View

13.

Zikopoulos K, West C, Thong P, Kacser E, Morrison J, Wu F . Homologous intra-uterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility. Hum Reprod. 1993; 8(4):563-7. DOI: 10.1093/oxfordjournals.humrep.a138096. View

14.

Callahan T, Hall J, Ettner S, Christiansen C, Greene M, Crowley Jr W . The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med. 1994; 331(4):244-9. DOI: 10.1056/NEJM199407283310407. View

15.

Sikandar R, Virk S, Lakhani S, Sahab H, Rizvi J . Intrauterine insemination with controlled ovarian hyperstimulation in the treatment of subfertility. J Coll Physicians Surg Pak. 2006; 15(12):782-5. DOI: 12.2005/JCPSP.782785. View

16.

Hughes E . The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod. 1997; 12(9):1865-72. DOI: 10.1093/humrep/12.9.1865. View

17.

Kaplan P, Austin D, Freund R . Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles. Am J Obstet Gynecol. 2000; 182(6):1421-6. DOI: 10.1067/mob.2000.106131. View

18.

Filicori M, Cognigni G, Pocognoli P, Tabarelli C, Ferlini F, Perri T . Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril. 2003; 80(2):390-7. DOI: 10.1016/s0015-0282(03)00594-6. View

19.

Guzick D, SULLIVAN M, Adamson G, Cedars M, Falk R, Peterson E . Efficacy of treatment for unexplained infertility. Fertil Steril. 1998; 70(2):207-13. DOI: 10.1016/s0015-0282(98)00177-0. View

20.

Iberico G, Vioque J, Ariza N, Lozano J, Roca M, Llacer J . Analysis of factors influencing pregnancy rates in homologous intrauterine insemination. Fertil Steril. 2004; 81(5):1308-13. DOI: 10.1016/j.fertnstert.2003.09.062. View